{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:02:41Z","timestamp":1784595761704,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53288-8","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:36:07Z","timestamp":1779204967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombin III at admission as a new predictive factors for mortality in ECMO for cardiogenic shock caused by acute myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Jing-bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-gang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-fu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"53288_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s13104-015-1678-7","volume":"8","author":"AK Gerke","year":"2015","unstructured":"Gerke, A. K. et al. Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007. BMC Res. Notes. 8, 686 (2015).","journal-title":"BMC Res. Notes."},{"key":"53288_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcrc.2017.02.014","volume":"39","author":"E Sy","year":"2017","unstructured":"Sy, E. et al. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta analysis. J. Crit. Care. 39, 87\u201396 (2017).","journal-title":"J. Crit. Care."},{"key":"53288_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12514","volume":"112","author":"SA Esper","year":"2017","unstructured":"Esper, S. A. et al. Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques. Vox. Sang. 112, 443\u2013452 (2017).","journal-title":"Vox. Sang."},{"key":"53288_CR4","unstructured":"The Extracorporeal Life Support Organization (ELSO). Extracorporeal Life Support Organization (ELSO) general guidelines for all ECLS cases. Available online https:\/\/www.elso.org\/Portals\/0\/Files\/ elsoanticoagulationguideline8\u20132014-table-contents.pdf."},{"key":"53288_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi, M. & Ten Cate, H. Disseminated intravascular coagulation. N. Engl. J. Med. 341, 586\u2013592 (1999).","journal-title":"N. Engl. J. Med."},{"key":"53288_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00134-005-2685-2","volume":"31","author":"M Sivula","year":"2005","unstructured":"Sivula, M., Tallgren, M. & Pettil\u00e4, V. Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med. 31, 1209\u20131214 (2005).","journal-title":"Intensive Care Med."},{"key":"53288_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","volume":"20","author":"JE Millar","year":"2016","unstructured":"Millar, J. E. et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit. Care 20, 387 (2016).","journal-title":"Crit. Care"},{"key":"53288_CR8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.21037\/jtd.2018.02.28","volume":"10","author":"HS Kim","year":"2018","unstructured":"Kim, H. S. et al. Early changes in coagulation profiles and lactate levels in patients with septic shock undergoing extracorporeal membrane oxygenation. J. Thorac Dis. 10, 1418\u20131430 (2018).","journal-title":"J. Thorac Dis."},{"key":"53288_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/MAT.0000000000001333","volume":"67","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Disseminated intravascular coagulation score is related to short-term mortality in patients undergoing venoarterial extracorporeal membrane oxygenation after cardiac surgery. ASAIO J. 67, 891\u2013898 (2021).","journal-title":"ASAIO J."},{"key":"53288_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","volume":"67","author":"PS Maclean","year":"2007","unstructured":"Maclean, P. S. & Tait, R. C. Hereditary and acquired antithrombin deficiency: Epidemiology, pathogenesis and treatment options. Drugs 67, 1429\u20131440 (2007).","journal-title":"Drugs"},{"key":"53288_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MAT.0000000000000010","volume":"60","author":"JW Byrnes","year":"2014","unstructured":"Byrnes, J. W. et al. Antithrombin III at admission supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life. ASAIO J. 60, 57\u201362 (2014).","journal-title":"ASAIO J."},{"key":"53288_CR12","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","volume":"48","author":"M Panigada","year":"2020","unstructured":"Panigada, M. et al. A randomized controlled trial of Antithrombin supplementation during extracorporeal membrane oxygenation. Crit. Care Med. 48, 1636\u20131644 (2020).","journal-title":"Crit. Care Med."},{"key":"53288_CR13","doi-asserted-by":"publisher","first-page":"107602962094111","DOI":"10.1177\/1076029620941112","volume":"26","author":"H Wada","year":"2020","unstructured":"Wada, H. et al. Severe Antithrombin deficiency may be associated with a high risk of pathological progression of DIC with suppressed fibrinolysis. Clin. Appl. Thromb. Hemost. 26, 107602962094111 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"53288_CR14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1053\/j.jvca.2018.11.014","volume":"33","author":"L Ruggeri","year":"2019","unstructured":"Ruggeri, L. et al. Coagulation derangements in patients with refractory cardiac arrest treated with extracorporeal cardiopulmonary resuscitation. J. Cardiothorac Vasc Anesth. 33, 1877\u20131882 (2019).","journal-title":"J. Cardiothorac Vasc Anesth."},{"key":"53288_CR15","doi-asserted-by":"publisher","first-page":"107602962094111","DOI":"10.1177\/1076029620941112","volume":"26","author":"H Wada","year":"2020","unstructured":"Wada, H. et al. Severe Antithrombin deficiency may be associated with a high risk of pathological progression of DIC with suppressed fibrinolysis. Clin. Appl. Thromb. Hemost. 26, 107602962094111 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"53288_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/02676591241288793","volume":"40","author":"KM Raja","year":"2025","unstructured":"Raja, K. M. et al. Hypoalbuminemia is a predictor of mortality in patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation. Perfusion 40(5), 1193\u20131201 (2025).","journal-title":"Perfusion"},{"issue":"1","key":"53288_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-0492-2-15","volume":"2","author":"H Wada","year":"2014","unstructured":"Wada, H., Matsumoto, T. & Yamashita, Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J. Intensive Care 2(1), 15 (2014).","journal-title":"J. Intensive Care"},{"issue":"10","key":"53288_CR18","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1097\/01.CCM.0000181296.53204.DE","volume":"33","author":"GT Kinasewitz","year":"2005","unstructured":"Kinasewitz, G. T. et al. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit. Care Med. 33(10), 2214\u20132221 (2005).","journal-title":"Crit. Care Med."},{"key":"53288_CR19","doi-asserted-by":"publisher","first-page":"S325","DOI":"10.1097\/00003246-200205001-00024","volume":"30","author":"SM Opal","year":"2002","unstructured":"Opal, S. M. et al. Antithrombin, heparin, and heparan sulfate. Crit. Care Med. 30, S325\u2013S331 (2002).","journal-title":"Crit. Care Med."},{"key":"53288_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/0885066618776937","volume":"35","author":"C Delmas","year":"2020","unstructured":"Delmas, C. et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the anti-Xa activity assay. J. Intensive Care Med. 35, 679\u2013686 (2020).","journal-title":"J. Intensive Care Med."},{"key":"53288_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MAT.0000000000000806","volume":"65","author":"GE Iapichino","year":"2019","unstructured":"Iapichino, G. E. et al. Antithrombin during extracorporeal membrane oxygenation in adults: National Survey and retrospective analysis. ASAIO J. 65, 257\u2013263 (2019).","journal-title":"ASAIO J."},{"issue":"1","key":"53288_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1051\/ject\/201446084","volume":"46","author":"KS Niimi","year":"2014","unstructured":"Niimi, K. S. & Fanning, J. J. Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation. J. Extra Corpor. Technol. 46(1), 84\u201390 (2014).","journal-title":"J. Extra Corpor. Technol."},{"key":"53288_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1089253209347384","volume":"13","author":"WC Oliver","year":"2009","unstructured":"Oliver, W. C. Anticoagulation and coagulation management for ECMO. Semin. Cardiothorac. Vasc. Anesth. 13, 154\u2013175 (2009).","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"53288_CR24","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","volume":"14","author":"MM Bembea","year":"2013","unstructured":"Bembea, M. M. et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr. Crit. Care Med. 14, e77-84 (2013).","journal-title":"Pediatr. Crit. Care Med."},{"key":"53288_CR25","doi-asserted-by":"publisher","first-page":"2s","DOI":"10.1016\/0002-9343(89)80523-6","volume":"87","author":"RD Rosenberg","year":"1989","unstructured":"Rosenberg, R. D. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am. J. Med. 87, 2s\u20139s (1989).","journal-title":"Am. J. Med."},{"key":"53288_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0022-5223(03)00392-1","volume":"126","author":"A Koster","year":"2003","unstructured":"Koster, A. et al. High antithrombin III at admission levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 126, 906\u2013907 (2003).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"53288_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","volume":"130","author":"MS Avidan","year":"2005","unstructured":"Avidan, M. S. et al. Recombinant human anti thrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 130, 107\u2013113 (2005).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"53288_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jtcvs.2017.01.053","volume":"153","author":"J Hoefer","year":"2017","unstructured":"Hoefer, J. et al. Innsbruck Liver-in-Heart-Failure Program. Antithrombin III at admission is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support. J. Thorac. Cardiovasc. Surg. 153(6), 1374\u20131382 (2017).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"53288_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.athoracsur.2006.02.056","volume":"82","author":"D Hoefer","year":"2006","unstructured":"Hoefer, D. et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann. Thorac. Surg. 82, 28\u201333 (2006).","journal-title":"Ann. Thorac. Surg."},{"key":"53288_CR30","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","volume":"367","author":"BA Bart","year":"2012","unstructured":"Bart, B. A. et al. For the Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N. Engl. J. Med. 367, 2296\u20132304 (2012).","journal-title":"N. Engl. J. Med."},{"key":"53288_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5754\/hge11317","volume":"59","author":"S Isik","year":"2012","unstructured":"Isik, S. et al. Anti thrombin prevents apoptosis by regulating inflammation in the liver in a model of cold ischemic\/warm reperfusion injury. Hepatogastroenterology 59, 453\u2013457 (2012).","journal-title":"Hepatogastroenterology"},{"key":"53288_CR32","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.96.7.2302","volume":"96","author":"L Ostrovski","year":"1997","unstructured":"Ostrovski, L., Woodman, R. C., Payne, D., Teoh, D. & Kubes, P. Antithrombin III at admission prevents and rapidly reverses leucocyte recruitment in ischemia\/reperfusion. Circulation 96, 2302\u20132310 (1997).","journal-title":"Circulation"},{"key":"53288_CR33","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/00003246-200107001-00016","volume":"29","author":"JF Dhainaut","year":"2001","unstructured":"Dhainaut, J. F. et al. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit. Care Med. 29, S42\u2013S47 (2001).","journal-title":"Crit. Care Med."},{"key":"53288_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejheart.2003.12.008","volume":"6","author":"C Denis","year":"2004","unstructured":"Denis, C. et al. Acute hypoxic hepatitis (\u2018\u201cliver shock\u201d\u2019): still a frequently overlooked cardiologic diagnosis. Eur. J. Heart. Fail. 6, 561\u2013565 (2004).","journal-title":"Eur. J. Heart. Fail."},{"issue":"4","key":"53288_CR35","first-page":"266","volume":"22","author":"KM Nelson","year":"2017","unstructured":"Nelson, K. M. et al. Continuous Antithrombin III at admission Administration in Pediatric Veno-Arterial Extracorporeal Membrane Oxygenation. J. Pediatr. Pharmacol. Ther. 22(4), 266\u2013271 (2017).","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"5 suppl 1","key":"53288_CR36","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/PCC.0b013e318292dfa7","volume":"14","author":"G Annich","year":"2013","unstructured":"Annich, G. & Adachi, I. Anticoagulation for pediatric mechanical circulatory support. Pediatr. Crit. Care Med. 14(5 suppl 1), S37\u2013S42 (2013).","journal-title":"Pediatr. Crit. Care Med."},{"issue":"10","key":"53288_CR37","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","volume":"67","author":"PS Maclean","year":"2007","unstructured":"Maclean, P. S. & Tait, R. C. Hereditary and acquired anti thrombin deficiency: Epidemiology, pathogenesis and treatment options. Drugs 67(10), 1429\u20131440 (2007).","journal-title":"Drugs"},{"issue":"8","key":"53288_CR38","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.21037\/jtd.2019.08.44","volume":"11","author":"E Colman","year":"2019","unstructured":"Colman, E. et al. Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature. J. Thorac. Dis. 11(8), 3325\u20133335 (2019).","journal-title":"J. Thorac. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53288-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:10:58Z","timestamp":1784592658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53288-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53288"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53288-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8827716\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment protocol for involving humans was in accordance to Helsinki Statement and national guidelines and was approved by the Medical Ethics Committee of The People\u2019s Hospital of Guangxi Zhuang Autonomous Region (no. PGRT0216), the Medical Ethics Committee of The Second People\u2019s Hospital of Qinzhou City (no. QZ201811), the Medical Ethics Committee of The People\u2019s Hospital of Lingshan (no. L1826), and the Medical Ethics Committee of The People\u2019s Hospital of Pubei (no.PB 201826). Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22800"}}